Company CVAbout Suven Life Sciences Ltd 
Suven Life Sciences Ltd
Small Cap
Pharmaceuticals & Drugs
Suven Life Sciences Limited (Formerly known as Suven Pharmaceuticals Ltd) was incorporated in March, 1989. The Company changed its name from Suven Pharmaceuticals Limited to Suven Life Sciences Limited in September, 2003. Promoted by Sudharani Jasti and Venkateswarlu Jasti, the Company began operations in 1989 as specialty chemicals provider.
Company Coordinates
Company Details
#8-2-334 SDE Serene Chambers, 6 th Floor Road No 5 Avenue 7 Hyderabad Telangana : 500034
Registrar Details
Karvy Computershare Pvt Ltd, Plot No 17-24 , Near Image Hospital,, Reliance Cybervilae,Vithalrao Nagar,, Madhapur, Hyderabad
Capital StructureCapital Structure
Present Equity Capital
INR 21.81 Cr
Number of Shares
21.81 Cr
Face Value
INR 0.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
17-Oct-2022
21.81
21.81
72691239
0
Right Issues
17-Oct-2022
21.81
21.81
72691239
1
Right Issues
28-Mar-2022
14.54
14.54
18100000
0
Conversion of Warrants
28-Mar-2022
14.54
14.54
18100000
1
Conversion of Warrants
03-Dec-2014
12.73
12.73
10453690
1
QIB Equity Shares
03-Dec-2014
12.73
12.73
10453690
1
QIB Equity Shares
03-Dec-2014
12.73
12.73
10453690
1
Issued to QIBs
29-Jan-2013
11.68
11.68
96800
1
ESOP
29-Jan-2013
11.68
11.68
96800
1
ESOP
12-Nov-2010
11.67
11.67
195740
1
ESOP
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 4 Schemes (1.05%)
FIIs
Held by 14 FIIs (0.34%)
Promoter with highest holding
Jasti Property And Equity Holdings Private Limited (initscapacityassoletrusteeofjastifamilytrust) (69.56%)
Highest Public shareholder
Rambabu Chirumamilla (1.38%)
Individual Investors Holdings
22.31%
Board of Directors
Management
Designation
Remuneration
Venkateswarlu Jasti
Chairman & CEO
0
Sudha Rani Jasti
Whole-time Director
99.91 lacs
Seyed E Hasnain
Director
2.3 lacs
M Gopalakrishna
Independent Director
3.5 lacs
Santanu Mukherjee
Independent Director
3.3 lacs
J A S Padmaja
Independent Director
1.7 lacs
Shrenik Soni
Company Sec. & Compli. Officer
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Services
49.88
7.52%
Export Incentives
16.92
2.55%
Duty Drawback
1.23
0.19%
Services
Services
Export Incentives
Export Incentives
Duty Drawback
Duty Drawback
Stock DNARevenue and Profits:
Net Sales:
2 Cr
(Quarterly Results - Dec 2024)
Net Profit:
-39 Cr
Pharmaceuticals & Drugs
INR 2,671 Cr (Small Cap)
NA (Loss Making)
33
0.00%
-0.86
-75.76%
13.53
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
